Axial Biotech Announces $4.1 Million Series A Financing

Axial Biotech has announced that it has completed its Series A round of financing, which raised $4.1 million. Axial is an innovative spine company developing genetic diagnostic and prognostic tests and minimally invasive, motion-preserving devices to advance the diagnosis and treatment of diseases and deformities of the human spine.

BioSpace

(http://www.biospace.com/news_story.cfm?StoryID=19238520&full=1)